Assessing risk of breast cancer: Tools for evaluating a patient's 5- year and lifetime probabilities

Postgraduate Medicine

Volumn 105, Issue 6, 1999, Pages 49-58

  Vogel, Victor G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CANCER; CANCER MODEL; CANCER RISK; CONFERENCE PAPER; FAMILY HISTORY; GENETIC COUNSELING; HUMAN; INCIDENCE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

EID: 0033563210     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.1080/00325481.1999.11444922     Document Type: Conference Paper

References (14)

1. Vogel VG. Evaluation of risk and preventive approaches to breast cancer. In: Kavanagh JJ, Singletary SE, Einhorn N, et al, eds. Cancer in women. Malden, Mass: Blackwell Science 1998:58-91
2. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early-onset breast cancer: implications for risk prediction. Cancer 1994;73(3):643-51
3. Berry DA, Parmigiani G, Sanchez J, et al. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997;89(3):227-38
4. Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 1998;62(3):676-89
5. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266(5182):66-71
6. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995;56(1):265-71
7. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265(5181):2088-90
8. Hunter DJ, Spiegelman D, Adami HO, et al. Cohort studies of fat intake and the risk of breast cancer: a pooled analysis. N Engl J Med 1996;334(6):356-61
9. Vogel VG. High-risk populations as targets for breast cancer prevention trials. Prev Med 1991;20(1):86-100
10. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81(24): 1879-86
11. Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90(18):1371-88
12. Spiegelman D, Colditz GA, Hunter D, et al. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994;86(8):600-7
13. Bondy ML, Lustbader ED, Halabi S, et al. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994;86(8):620-5
14. Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998;62(1):145-58